15,16-Dihydrotanshinone I, a novel β-catenin-targeting inhibitor that inhibits its nuclear translocation and reduces downstream CD36 expression in cancer

Minting Chen(Hong Kong Baptist University), Hiu Yee Kwan(Hong Kong Baptist University)

Journal of Translational Medicine

November 21, 2025

10.1186/s12967-025-07317-1

Cited by 0

Related Papers

Medicinal herbs and bioactive compounds overcome the drug resistance to epidermal growth factor receptor inhibitors in non‑small cell lung cancer (Review)

|Oncology Letters|2021|28

Elevated extracellular matrix protein 1 in circulating extracellular vesicles supports breast cancer progression under obesity conditions

|Nature Communications|2024|26